Mit speziellen Wirkstoffen bei DOT beschichteter Stent

Coating of Balloon Catheters


Technology

At DOT, the balloon catheters are coated with cytostatic drugs. Application of these active substances is conducted with a defined deposition of an adjusted solution and their drying. The cytostatic drugs are applied on the balloon catheter using a carrier substance and generate a so-called drug eluting balloon (DEB). During the dilatation of the balloon in the blood vessel, the cytostatic drug is released from the balloon into the vessel wall and minimises the risk of restenosis for a specified period of time.
coaedt balloon catheter
Properties
  • Homogenous, thin coating
  • Drug release over a defined time period
Range of Application
  • Balloon catheters for angioplasty of peripheric and coronar blood vessels
  • In-stent restenosis
  • Bifurcations in the coronar area as well as renal vessels, femoral arteries and lower leg arteries in the peripheral area
Advantages of the Procedure
  • No foreign body in the blood vessel after after medical intervention
  • Effective inhibition of new formation of cells
  • Permanent local effectiveness of the released substances over a long time period
Coating-Catheter-Safety-workbench
coated balloon catheter SEM picture

DOT GmbH
Charles-Darwin-Ring 1a
18059 Rostock l Germany

Phone: +49 381- 4 03 35-0
Fax: +49 381- 4 03 35-99

AEO DQS Logo
© 2020 DOT GmbH. All Rights Reserved.

Please publish modules in offcanvas position.